About Us

Committed to improving research and development productivity for organizations around the world through better science and technology.

License to Cure Webinars

The challenge to adapt to a continually changing regulatory environment while striving to reduce cost and develop more effective therapeutics has arisen as one of the key hurdles to success in today’s life science industries. Any deviation or compliance issue, no matter how small, can significantly impact the overall success of new releases as well as the organization as a whole. As biotherapeutics organizations continue to externalize, teams must be able to effectively communicate and share growing numbers of documents and regulatory information.

Current document and quality management systems are proving too inefficient and outdated to continue to be sustainable in this environment. Paper versions of key documents can be lost or damaged, manual transcription of data can result in errors, and multiple versions of the same document can increase approval time. All of this inefficiency and inflexibility causes delays in the documentation and review process and can lead to serious compliance issues with regulatory bodies.

The License to Cure Industry Solution Experience combines Quality, Regulatory, and Compliance teams with a comprehensive electronic and quality management system, facilitating a streamlined, open regulatory management environment. It empowers leadership with improved insight into their regulatory and compliance initiatives, ultimately accelerating therapeutic approval, production, and patient adoption in a global landscape.

Upcoming Webinars

Date Title and Speaker
March 6, 2019
8:00 a.m. PST
11:00 a.m. EST
5:00 p.m. CEST

QUMAS Cloud for EDMS, EQMS, and LMS – Integrated and Scalable
Snehal Srikrishna, Director, PwC USA and Vitaly Glozman, PwC USA, Partner

QUMAS Cloud is an integrated and scalable platform for EDMS, EQMS, and LMS. Fully managed and supported by BIOVIA – so you can focus on running your business.

Many organizations in the highly regulated Life Sciences industry have difficulty managing quality data, documents and processes across the enterprise. Geographical barriers, data silos, and regulatory challenges are among the hindrances to smooth operations whether in the audit process or not.

BIOVIA, Dassault Systèmes is now offering QUMAS, the industry leading regulatory, compliance and quality management solution, as a SaaS solution in the cloud. We are inviting you to this webinar to show you the possibilities to move to the cloud and the benefits of the QUMAS Cloud solution built on Amazon Web Services.

In this webinar you will learn:

  • About the beneUfits of the QUMAS Cloud solution
  • How to move your current QUMAS Hosted solution to the QUMAS Cloud
  • How to move your current QUMAS On-Premises deployment to the QUMAS Cloud
  • How this deployment fits into your digitalization strategy
  • How this strategy fits into the overall long term strategy of Dassault Systèmes
 Register Now

Past Webinars

Title and Speaker

The Data Enabled Revolution in Formulations Development
Murtuza U, BIOVIA Director, Technical Sales, Global Quality and Compliance BIOVIA, Dassault Systèmes

The biopharma industry has had major paradigm shifts in recent years for the development and commercialization of established and emerging categories of therapeutics.

Today’s webinar will provide a perspective on these major trends and challenges and discuss key capabilities needed for next generation CMC development including:

  • Phase-appropriate CMC development approaches e.g. Quality by Design (QbD) approaches to improve product quality and accelerate time to market
  • Integrated CMC development strategies e.g. drug-device combination products
  • Product Lifecycle Management e.g. data for process characterization & development and managing product variations
  • Oversight & Risk Management process to improve the efficiency and effectiveness of CMC development with external CMC partners

 Watch Now

Introducing License to Cure for BioPharma – Industry Solution Experience

Pharmaceutical and biotech companies need an effective way to adapt and manage their processes in order to industry demands such as competition, globalization, lower margins and increasing regulatory requirements. Adding to these challenges is the fact that functional areas within organizations often have their own silos of content not easily shared with each other.

Dassault Systèmes License to Cure for BioPharma provides an integrated, online platform where companies can digitally share activities across their global operations. By focusing on the therapeutic lifecycle, the solution creates a seamless and continuous data flow that enables transparency from clinical activity through manufacturing and full commercialization.

License to Cure provides a connected and comprehensive regulatory and quality platform to accelerate therapeutic approval, production and patient adoption in a global landscape.

Join us for the webinar as we will cover:

  • The latest trends and challenges facing the pharmaceutical and biotech industries
  • How the License to Cure for BioPharma can address those challenges
  • Examples of organizations that have used the capabilities of License to Cure and the benefits they have gained

 Watch Now


Browse By: